Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2016 - 2018)

Kazia Therapeutics (KZIA) reported Depreciation & Amortization - Total of $73.89 for Q4 2018, down 99.95% on a YoY basis from $156425.5 in Q4 2017, and down 99.95% quarter-over-quarter from $156425.5 in Q4 2017.

Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2016 - 2018) Analysis & Trends

Kazia Therapeutics has reported Depreciation & Amortization - Total for 3 years, with the latest figure at $73.89 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Kazia Therapeutics 1.70 Bn 1.70 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 73.89
Dec 31, 2017 156,425.52
Dec 31, 2016 37,384.89